505 related articles for article (PubMed ID: 34487060)
1. COVID-19 vaccine effectiveness among the staff of the Bologna Health Trust, Italy, December 2020-April 2021.
Giansante C; Stivanello E; Perlangeli V; Ferretti F; Marzaroli P; Musti MA; Pizzi L; Resi D; Saraceni S; Pandolfi P
Acta Biomed; 2021 Sep; 92(4):e2021270. PubMed ID: 34487060
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
3. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.
Pawlowski C; Lenehan P; Puranik A; Agarwal V; Venkatakrishnan AJ; Niesen MJM; O'Horo JC; Virk A; Swift MD; Badley AD; Halamka J; Soundararajan V
Med; 2021 Aug; 2(8):979-992.e8. PubMed ID: 34223401
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study.
Barzegar M; Manteghinejad A; Afshari-Safavi A; Mirmosayyeb O; Nasirian M; Bagherieh S; Mazaheri S; Rahimi M; Zabeti A; Javanmard SH; Shaygannejad V
Mult Scler Relat Disord; 2023 Mar; 71():104548. PubMed ID: 36827877
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.
Moline HL; Whitaker M; Deng L; Rhodes JC; Milucky J; Pham H; Patel K; Anglin O; Reingold A; Chai SJ; Alden NB; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Farley MM; Ryan PA; Kim S; Nunez VT; Como-Sabetti K; Lynfield R; Sosin DM; McMullen C; Muse A; Barney G; Bennett NM; Bushey S; Shiltz J; Sutton M; Abdullah N; Talbot HK; Schaffner W; Chatelain R; Ortega J; Murthy BP; Zell E; Schrag SJ; Taylor C; Shang N; Verani JR; Havers FP
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1088-1093. PubMed ID: 34383730
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
Fowlkes A; Gaglani M; Groover K; Thiese MS; Tyner H; Ellingson K;
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1167-1169. PubMed ID: 34437521
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mRNA COVID-19 Vaccines in Adolescents Over 6 Months.
Amodio E; Genovese D; Mazzeo L; Martino L; Restivo V; Vella G; Calamusa G; Vitale F
Pediatrics; 2022 Nov; 150(5):. PubMed ID: 35945678
[TBL] [Abstract][Full Text] [Related]
8. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis.
Zheng C; Shao W; Chen X; Zhang B; Wang G; Zhang W
Int J Infect Dis; 2022 Jan; 114():252-260. PubMed ID: 34800687
[TBL] [Abstract][Full Text] [Related]
9. A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.
Gujar N; Tambe M; Parande M; Salunke N; Jagdale G; Anderson SG; Dharmadhikari A; Lakhkar A; Kulkarni PS
Hum Vaccin Immunother; 2021 Oct; 17(10):3316-3321. PubMed ID: 34128766
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
Xu S; Huang R; Sy LS; Glenn SC; Ryan DS; Morrissette K; Shay DK; Vazquez-Benitez G; Glanz JM; Klein NP; McClure D; Liles EG; Weintraub ES; Tseng HF; Qian L
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1520-1524. PubMed ID: 34710075
[TBL] [Abstract][Full Text] [Related]
11. [Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology].
Sinagra G; Porcari A; Merlo M; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Spaccarotella C; Filardi PP; Indolfi C
G Ital Cardiol (Rome); 2021 Nov; 22(11):894-899. PubMed ID: 34709228
[TBL] [Abstract][Full Text] [Related]
12. Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.
Mateo-Urdiales A; Spila Alegiani S; Fabiani M; Pezzotti P; Filia A; Massari M; Riccardo F; Tallon M; Proietti V; Del Manso M; Puopolo M; Spuri M; Morciano C; D'Ancona FP; Da Cas R; Battilomo S; Bella A; Menniti-Ippolito F; ;
Euro Surveill; 2021 Jun; 26(25):. PubMed ID: 34169819
[TBL] [Abstract][Full Text] [Related]
13. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
Singh C; Naik BN; Pandey S; Biswas B; Pati BK; Verma M; Singh PK
Epidemiol Infect; 2021 Oct; 149():e224. PubMed ID: 34632972
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
Nojszewska M; Kalinowska A; Adamczyk-Sowa M; Kułakowska A; Bartosik-Psujek H
Neurol Neurochir Pol; 2021; 55(1):8-11. PubMed ID: 33555604
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
Martínez-Baz I; Miqueleiz A; Casado I; Navascués A; Trobajo-Sanmartín C; Burgui C; Guevara M; Ezpeleta C; Castilla J;
Euro Surveill; 2021 May; 26(21):. PubMed ID: 34047271
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
18. [Current state of vaccination against SARS-CoV-2].
Iking-Konert C; Specker C; Krüger K; Schulze-Koops H; Aries P
Z Rheumatol; 2021 Mar; 80(2):158-164. PubMed ID: 33528655
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of COVID-19 vaccines in a large European hemodialysis cohort.
Bernardo AP; Carioni P; Stuard S; Kotanko P; Usvyat LA; Kovarova V; Arkossy O; Bellocchio F; Tupputi A; Gervasoni F; Winter A; Zhang Y; Zhang H; Ponce P; Neri L
Front Nephrol; 2022; 2():1037754. PubMed ID: 37675035
[TBL] [Abstract][Full Text] [Related]
20. Bhutan's COVID-19 Vaccination Efforts and the Evolution of COVID-19 Cases in the Aftermath.
Gyeltshen D; Dema T; Ahmadi A; Lucero-Prisno DE
Asia Pac J Public Health; 2022 Jan; 34(1):125-127. PubMed ID: 34670431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
